Skip to main content
Equibles

Legal & General Group Plc

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 764068 London, X0
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,014,326
+$239,083 QoQ
Shares Held
56,477
+1.3% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 207 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. AMLX ranks #28 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,567,388 $256,352,500
2 TEVA
Teva Pharmaceutical Industries Ltd
 3,916,666 $132,696,643
3 UTHR
UNITED THERAPEUTICS Corp
 207,093 $112,209,199
4 VTRS
Viatris Inc
 4,069,647 $64,625,993
5 NBIX
Neurocrine Biosciences Inc
 314,451 $52,997,570
6 ALKS
Alkermes plc.
 393,524 $20,620,657
7 ELAN
Elanco Animal Health Inc
 711,233 $17,503,443
8 XERS
Xeris Biopharma Holdings, Inc.
 2,012,792 $15,941,311

All Filings in AMLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,014,326 56,477
2026-03-31 $775,243 55,773
2025-12-31 $877,152 72,612
2025-09-30 $913,410 67,212
2025-06-30 $47,446 7,402
2024-03-31 $93,304 32,854
2023-12-31 $583,883 39,666
2023-09-30 $587,787 32,102
2023-06-30 $615,089 28,516
2023-03-31 $793,705 27,052
2022-12-31 $185,599 5,023
2022-09-30 $97,427 3,461
2022-06-30 $23,574 1,224
2022-03-31 $11,629 905